Home Floelle - Floelle Inc.

One in three U.S. women worries about SUI.

Don’t you deserve to be worry free?

Welcome to Floelle, Inc.

Floelle, Inc. has developed a minimally invasive Class II medical device for the treatment of stress urinary incontinence (SUI) for women of all ages.

Contact Us

Our Vision

Our vision is to offer women worldwide a convenient alternative for the treatment of stress urinary incontinence (SUI). Floelle intends to become the leader in female pelvic health.

Our Mission

Our mission is to liberate women from the embarrassment, insecurity, and cost of using sanitary paper products, external hand-held devices, or surgery, with our by-prescription–only, minimally-invasive, anti-microbial device for the treatment of stress urinary incontinence (SUI).

Our Solution

Floelle™ is a simple tubular device that is placed in a woman’s urethra by her doctor in the Examination Room. This blocks urinary leakage when abdominal pressure is high. To prevent encrustation, Floelle is replaced three times a year by her doctor and eliminates the need for her previously needed alternate means of protection.

We’re not just offering a solution; we’re providing a lifestyle change. Join the countless individuals looking forward to reclaiming their confidence with Floelle.

Tapping into Growth: The Lucrative Future of Stress Urinary Incontinence Solutions

Stress Urinary Incontinence (SUI) is the unintentional loss of urine when physical movement or activity, such as coughing, laughing, sneezing, running, or heavy lifting, puts pressure (stress) on your bladder.

The Stress Urinary Incontinence (SUI) market presents a substantial and burgeoning opportunity for investors, fueled by a growing global demand for effective solutions in women’s health. With an aging population and increased awareness about healthcare, the prevalence of SUI is on the rise, creating a significant market size that is poised for expansion. The market potential is underscored by the fact that millions of individuals worldwide are actively seeking discrete and advanced interventions to address the challenges posed by SUI, making it a lucrative space for investors keen on tapping into the intersection of medical innovation and market growth.

Furthermore, the SUI market’s potential is magnified by advancements in medical technology and a paradigm shift towards minimally invasive procedures and innovative therapeutic options. As the healthcare landscape evolves, investors have a unique opportunity to support companies at the forefront of SUI research and development. With the convergence of a considerable patient demographic, unmet medical needs, and technological advancements, the Stress Urinary Incontinence market stands as an attractive and dynamic sector for investors looking to make a meaningful impact while realizing substantial returns.